Why these 4 ASX shares have started the week with a BANG

The Zelda Therapeutics Ltd (ASX:ZLD) share price is one of four starting the week strongly. Here's why the pot stock and these three shares are climbing higher today…

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

It hasn't been a great start to the week for the benchmark S&P/ASX 200 (Index: ^AXJO) (ASX: XJO). Due largely to declines in the materials sector, in afternoon trade the index is down 0.2% to 5,739 points.

But not all shares have fallen lower today. Four shares in particular have gone against the grain and climbed higher. Here's why:

The a2 Milk Company Ltd (Australia) (ASX: A2M) share price is up almost 3% to $2.68 despite there being no news out of the fast-growing dairy company. Today's gain means a2 Milk's shares have climbed a massive 21% since the start of the month. News that Chinese regulators have indefinitely postponed new cross border e-commerce laws has been the catalyst for the rally.

The Evolution Mining Ltd (ASX: EVN) share price has jumped over 4% to $2.14. Whilst the majority of Australia's leading gold miners have climbed higher today, Evolution was given an added boost from a number of broker reports. Credit Suisse, Macquarie, and UBS all reiterated their buy ratings this morning following site visits.

The Mayne Pharma Group Ltd (ASX: MYX) share price has climbed close to 3% to $1.38. Although there was no news out of the pharmaceutical company, I'm not surprised to see investors snap up its shares considering they change hands at just 12x annualised earnings. As I said earlier today, I think Mayne Pharma is one of three bargain buys on the ASX at the moment.

The Zelda Therapeutics Ltd (ASX: ZLD) share price has rocketed 15% to 9.5 cents after the medical marijuana company announced a strategic partnership with animal health company CannPal. Management believes the agreement will allow the two companies to exploit opportunities of mutual interest in both the human and animal pharmaceutical markets. Zelda will be granted options over 10% of CannPal, which plans to list on the ASX later this year.

Motley Fool contributor James Mickleboro has no position in any stocks mentioned. The Motley Fool Australia owns shares of A2 Milk. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »